• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
.Latest research progresss in biomarkers of heart failure[J].Journal Of Pharmaceutical Research,2020,39(11):670-675[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2459times   Download 2464次 QR Code for this article
Scan with your phone!
心力衰竭生物标志物的最新研究进展
贾雪1,2,王相阳2,马晓慧2,阿基业1
Font:Larger+|Default|Smaller-
(1.中国药科大学,江苏 南京 210009;2.天士力医药集团股份有限公司创新中药关键技术国家重点实验室,天津 300410)
摘要:
心力衰竭是一种复杂的临床综合症,在全球具有较高的发病率和死亡率。良好的生物标志物有助于疾病的危险分层和预后评估。目前利钠肽是唯一的生物标志物被录入心力衰竭的指南。近年来多种与心力衰竭病理过程相关的生物标志物相继出现,与纤维化相关的、与心肌细胞损伤相关的、与细胞基质重塑相关的等,这些生物标志物对心力衰竭的筛查鉴别以及疾病危险分层和预后评估都有一定的价值,本文将对这些生物标志物的进行总结分析。
关键词:  心力衰竭  生物标志物  临床应用  危险分层  预后评估
DOI:10.13506/j.cnki.jpr.2020.11.012
基金项目:
Publication Date:November 25, 2020
Latest research progresss in biomarkers of heart failure
()
Abstract:
Heart failure is a complex clinical syndrome with high incidence rate and mortality worldwide. Good biomarkers are helpful for risk stratification and prognosis assessment. At present, natriuretic peptide is the only biomarker to be entered into the guidelines of heart failure.In recent years,a variety of biomarkers related to the pathological process of heart failure have emerged one after another, which are related to fibrosis,myocardial cell injury,matrix remodeling and so on.These biomarkers have certain value for screening and differentiation of heart failure, disease risk stratification and prognosis evaluation. This paper summarized and analyzed these biomarkers.
Key words:  Heart failure  Biomarker  Clinical application  Risk stratification  Prognosis evaluation
Today's Visits:485    Total Visits:2383197
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.